Elion Therapeutics

Elion Therapeutics is a biotechnology company focused on developing novel antifungal treatments. Their lead candidate, SF001, is a next-generation polyene antifungal designed to reduce toxicity compared to existing options. The company aims to transform the treatment of life-threatening invasive fungal infections.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $81M

Date: 17-Jun-2024

Investors: Deerfield Management, AMR Action Fund, Illinois Ventures

Markets: Biotechnology, Pharmaceuticals, Therapeutics

HQ: Boston, Massachusetts, United States

Founded: 2018

Website: https://eliontx.com

LinkedIn: https://www.linkedin.com/company/eliontx

Twitter:

Instagram: